Filing Details
- Accession Number:
- 0001571049-17-005399
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-25 21:03:27
- Reporting Period:
- 2017-05-23
- Filing Date:
- 2017-05-25
- Accepted Time:
- 2017-05-25 21:03:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601607 | Bfi Co., Llc | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2017-05-23 | 72,975 | $0.00 | 96,000 | No | 4 | C | Direct | |
| Class A Common Stock | Disposition | 2017-05-23 | 16,000 | $34.46 | 80,000 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-05-24 | 16,000 | $34.75 | 64,000 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-05-25 | 16,000 | $34.80 | 48,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Class B Common Stock | Disposition | 2017-05-23 | 72,975 | $0.00 | 72,975 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,814,836 | No | 4 | C | Direct |
Footnotes
- The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $34.65, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $35.03, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.15, inclusive
Billionaire Hedge Funds
